Current Report Filing (8-k)
November 12 2020 - 6:17AM
Edgar (US Regulatory)
0001460602
false
0001460602
2020-10-10
2020-10-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 10, 2020
ORGENESIS
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
000-54329
|
|
98-0583166
|
(State
or other jurisdiction
|
|
(Commission
File
|
|
(IRS
Employer
|
of
incorporation
|
|
Number)
|
|
Identification
No.)
|
20271
Goldenrod Lane, Germantown, MD 20876
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (480) 659-6404
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
☐ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock
|
|
ORGS
|
|
The
Nasdaq Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
7.01 Regulation FD Disclosure
A
copy of a presentation that is intended to be used by representatives of Orgenesis Inc. (the “Company”) in meetings
with prospective investors and other parties, as well as on the Company’s website, is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
The
information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed
“filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10
of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of
1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language
in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.
Forward-Looking
Statements
This
Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, may contain “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included
in this Current Report on Form 8-K may constitute forward-looking statements and are not guarantees of future performance or results
and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements
as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission.
The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only
as of the date of this Current Report on Form 8-K.
Item
9.01 Financial Statements and Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
ORGENESIS
INC.
|
|
By:
|
|
|
|
/s/
Neil Reithinger
|
|
Neil
Reithinger
|
|
Chief
Financial Officer, Treasurer and Secretary
|
|
|
|
October
12, 2020
|
|
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Apr 2024 to May 2024
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From May 2023 to May 2024